Drug class
Methylene Blue
Rather than designating an entire therapeutic drug class, methylene blue is a specific synthetic active pharmaceutical ingredient that functions as an oxidation-reduction agent, an antidote, and a diagnostic dye. Read more about Methylene Blue
10 drugs in this class 9 manufacturers
Drugs in Methylene Blue
PROVAYBLUE (methylene blue)
METHYLENE BLUE
METHYLENE BLUE
METHYLENE BLUE
METHYLENE BLUE
METHYLENE BLUE
METHYLENE BLUE
METHYLENE BLUE
Rather than designating an entire therapeutic drug class, methylene blue is a specific synthetic active pharmaceutical ingredient that functions as an oxidation-reduction agent, an antidote, and a diagnostic dye.
Therapeutically, it is converted in erythrocytes to leucomethylene blue, which acts as an electron donor to reduce ferric iron back to the ferrous state, restoring the oxygen-carrying capacity of hemoglobin.
Its primary established medical indication is the treatment of acquired methemoglobinemia, alongside diagnostic visualization during surgical procedures and off-label critical-care applications such as refractory vasoplegic shock.
-
opss.org
Rather than designating an entire therapeutic drug class, methylene blue is a specific synthetic active pharmaceutical ingredient that functions as an oxidation-reduction agent, an antidote, and a diagnostic dye Its primary established medical indication is the treatment of acquired methemoglobinemia, alongside diagnostic visualization during surgical procedures and off-label critical-care applications such as refractory vasoplegic shock
-
drugs.com
Rather than designating an entire therapeutic drug class, methylene blue is a specific synthetic active pharmaceutical ingredient that functions as an oxidation-reduction agent, an antidote, and a diagnostic dye Therapeutically, it is converted in erythrocytes to leucomethylene blue, which acts as an electron donor to reduce ferric iron back to the ferrous state, restoring the oxygen-carrying capacity of hemoglobin Its primary established medical indication is the treatment of acquired methemogl...
-
nih.gov
Therapeutically, it is converted in erythrocytes to leucomethylene blue, which acts as an electron donor to reduce ferric iron back to the ferrous state, restoring the oxygen-carrying capacity of hemoglobin Its primary established medical indication is the treatment of acquired methemoglobinemia, alongside diagnostic visualization during surgical procedures and off-label critical-care applications such as refractory vasoplegic shock
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.